CyHLab has expanded its focus to the cardiovascular area, particularly in the prevention and treatment of diseases related to the formation of blood clots. These conditions, such as heart rhythm disorders, heart failure, heart attacks, and strokes, are responsible for a significant amount of illness and death worldwide.
 
The formation of blood clots, also known as thrombosis, is a natural process in the body, but when it goes out of control, it can lead to serious complications. In this context, strategies to prevent blood clots are essential to protect cardiovascular health and improve the quality of life for patients. Through specialized treatments, the goal is to reduce the risks associated with these conditions and minimize the most serious complications related to blood circulation problems.
 
CyHLab is committed to offering innovative and effective solutions in this field, contributing to a healthier future and protecting people’s well-being from cardiovascular diseases.